Inhibition of Netosis with PAD Inhibitor Attenuates Endotoxin Shock Induced Systemic Inflammation

Int J Mol Sci. 2022 Oct 31;23(21):13264. doi: 10.3390/ijms232113264.

Abstract

Neutrophils play a pivotal role in innate immunity by releasing neutrophils extracellular traps (NETs). Excessive NETs are detrimental to the local tissue and further exacerbate inflammation. Protein arginine deiminases (PAD) mediate histone citrullination and NET formation that, in turn, exacerbate endotoxin shock damages. In this study, we further investigated the molecular mechanism underlying PAD and NETs in endotoxic stress in mice. The control group mice were injected with solvent, the LPS endotoxic shock group mice were intraperitoneally injected with LPS at 35 mg/kg only, while the LPS and PAD inhibitor YW3-56 treatment group mice were injected with YW3-56 at 10 mg/kg prior to the LPS injection. YW3-56 significantly prolonged the survival time of the LPS-treated mice. NETs, cfDNA, and inflammatory factors were detected by ELISA in serum, paitoneal cavity, and lung at 24 h after LPS administration. Lung injuries were detected by immunostaining, and lung tissue transcriptomes were analyzed by RNA-seq at 24 h after LPS administration. We found that YW3-56 altered neutrophil tissue homeostasis, inhibited NET formation, and significantly decreased cytokines (IL-6, TNFα and IL-1β) levels, cytokines gene expression, and lung tissue injury. In summary, NET formation inhibition offers a new avenue to manage inflammatory damages under endotoxic stress.

Keywords: LPS; PAD inhibitor; RNA-seq; endotoxin shock; netosis; systemic inflammation.

MeSH terms

  • Animals
  • Cytokines / metabolism
  • Extracellular Traps* / metabolism
  • Inflammation* / drug therapy
  • Inflammation* / metabolism
  • Lipopolysaccharides / metabolism
  • Lipopolysaccharides / toxicity
  • Mice
  • Neutrophils / metabolism
  • Protein-Arginine Deiminases / antagonists & inhibitors
  • Protein-Arginine Deiminases / metabolism
  • Shock, Septic* / chemically induced
  • Shock, Septic* / drug therapy
  • Shock, Septic* / metabolism

Substances

  • Cytokines
  • Lipopolysaccharides
  • Protein-Arginine Deiminases
  • YW3-56